211 related articles for article (PubMed ID: 28835079)
1. [Effect of concurrent chemoradiotherapy and radiotherapy alone on peripheral myeloid-derived suppressor and T regulatory cells in patients with nasopharyngeal cancer].
Dai XC; Liu LQ; Wang BH; Wang CM; Ma L; Cao WM; Dai EX
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):579-583. PubMed ID: 28835079
[No Abstract] [Full Text] [Related]
2. Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy.
Chen HM; Ma G; Gildener-Leapman N; Eisenstein S; Coakley BA; Ozao J; Mandeli J; Divino C; Schwartz M; Sung M; Ferris R; Kao J; Wang LH; Pan PY; Ko EC; Chen SH
Clin Cancer Res; 2015 Sep; 21(18):4073-4085. PubMed ID: 25922428
[TBL] [Abstract][Full Text] [Related]
3. The study of CD14+HLA-DR-/low myeloid-drived suppressor cell (MDSC) in peripheral blood of peripheral T-cell lymphoma patients and its biological function.
Du J; Sun X; Song Y
Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):62-67. PubMed ID: 28466815
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab.
Sade-Feldman M; Kanterman J; Klieger Y; Ish-Shalom E; Olga M; Saragovi A; Shtainberg H; Lotem M; Baniyash M
Clin Cancer Res; 2016 Dec; 22(23):5661-5672. PubMed ID: 27178742
[TBL] [Abstract][Full Text] [Related]
5. Increased frequencies of CD11b(+) CD33(+) CD14(+) HLA-DR(low) myeloid-derived suppressor cells are an early event in melanoma patients.
Rudolph BM; Loquai C; Gerwe A; Bacher N; Steinbrink K; Grabbe S; Tuettenberg A
Exp Dermatol; 2014 Mar; 23(3):202-4. PubMed ID: 24495013
[TBL] [Abstract][Full Text] [Related]
6. Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients.
Napolitano M; D'Alterio C; Cardone E; Trotta AM; Pecori B; Rega D; Pace U; Scala D; Scognamiglio G; Tatangelo F; Cacciapuoti C; Pacelli R; Delrio P; Scala S
Oncotarget; 2015 Apr; 6(10):8261-70. PubMed ID: 25823653
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive role of CD11b
Hyun SY; Na EJ; Jang JE; Chung H; Kim SJ; Kim JS; Kong JH; Shim KY; Lee JI; Min YH; Cheong JW
Cancer Med; 2020 Oct; 9(19):7007-7017. PubMed ID: 32780544
[TBL] [Abstract][Full Text] [Related]
8. Prostaglanin-E2 Potentiates the Suppressive Functions of Human Mononuclear Myeloid-Derived Suppressor Cells and Increases Their Capacity to Expand IL-10-Producing Regulatory T Cell Subsets.
Tomić S; Joksimović B; Bekić M; Vasiljević M; Milanović M; Čolić M; Vučević D
Front Immunol; 2019; 10():475. PubMed ID: 30936876
[TBL] [Abstract][Full Text] [Related]
9. Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4(+) Foxp3(+) Treg expansion.
Luan Y; Mosheir E; Menon MC; Wilson D; Woytovich C; Ochando J; Murphy B
Am J Transplant; 2013 Dec; 13(12):3123-31. PubMed ID: 24103111
[TBL] [Abstract][Full Text] [Related]
10. CD33(+) /HLA-DR(neg) and CD33(+) /HLA-DR(+/-) Cells: Rare Populations in the Human Decidua with Characteristics of MDSC.
Bartmann C; Junker M; Segerer SE; Häusler SF; Krockenberger M; Kämmerer U
Am J Reprod Immunol; 2016 May; 75(5):539-56. PubMed ID: 26840716
[TBL] [Abstract][Full Text] [Related]
11. The success of assisted reproduction technologies in relation to composition of the total regulatory T cell (Treg) pool and different Treg subsets.
Schlossberger V; Schober L; Rehnitz J; Schaier M; Zeier M; Meuer S; Schmitt E; Toth B; Strowitzki T; Steinborn A
Hum Reprod; 2013 Nov; 28(11):3062-73. PubMed ID: 23925397
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines.
Lechner MG; Megiel C; Russell SM; Bingham B; Arger N; Woo T; Epstein AL
J Transl Med; 2011 Jun; 9():90. PubMed ID: 21658270
[TBL] [Abstract][Full Text] [Related]
13. STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer.
Oweida AJ; Darragh L; Phan A; Binder D; Bhatia S; Mueller A; Court BV; Milner D; Raben D; Woessner R; Heasley L; Nemenoff R; Clambey E; Karam SD
J Natl Cancer Inst; 2019 Dec; 111(12):1339-1349. PubMed ID: 30863843
[TBL] [Abstract][Full Text] [Related]
14. [Detection and clinical significance of myeloid-derived suppressor cells in peripheral blood of patients with rectal carcinoma].
Zhang Y; Xie J; Han G; Dong B; Zhang Y; Zhang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jul; 20(7):798-802. PubMed ID: 28722094
[TBL] [Abstract][Full Text] [Related]
15. Effect of nasopharyngeal carcinoma-derived exosomes on human regulatory T cells.
Mrizak D; Martin N; Barjon C; Jimenez-Pailhes AS; Mustapha R; Niki T; Guigay J; Pancré V; de Launoit Y; Busson P; Moralès O; Delhem N
J Natl Cancer Inst; 2015 Jan; 107(1):363. PubMed ID: 25505237
[TBL] [Abstract][Full Text] [Related]
16. [Correlation analysis of the Epstein-Barr virus recruited regulatory T cells in nasopharyngeal carcinoma of immune escape].
Bi P; Wang J; Lu J; Liu X; Wang F; Luo YF; Peng SD; Li XP
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep; 52(9):692-697. PubMed ID: 28910895
[No Abstract] [Full Text] [Related]
17. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.
Ren JP; Zhao J; Dai J; Griffin JW; Wang L; Wu XY; Morrison ZD; Li GY; El Gazzar M; Ning SB; Moorman JP; Yao ZQ
Immunology; 2016 Aug; 148(4):377-86. PubMed ID: 27149428
[TBL] [Abstract][Full Text] [Related]
19. Increased Levels of Circulating Monocytic- and Early-Stage Myeloid-Derived Suppressor Cells (MDSC) in Acute Myeloid Leukemia.
Lv J; Zhao Y; Zong H; Ma G; Wei X; Zhao Y
Clin Lab; 2021 Mar; 67(3):. PubMed ID: 33739029
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.
Kotsakis A; Harasymczuk M; Schilling B; Georgoulias V; Argiris A; Whiteside TL
J Immunol Methods; 2012 Jul; 381(1-2):14-22. PubMed ID: 22522114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]